These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 14632658)

  • 21. Clonal acquisition of inhibitory Ly49 receptors on developing NK cells is successively restricted and regulated by stromal class I MHC.
    Roth C; Carlyle JR; Takizawa H; Raulet DH
    Immunity; 2000 Jul; 13(1):143-53. PubMed ID: 10933402
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Allelic exclusion of Ly49-family genes encoding class I MHC-specific receptors on NK cells.
    Held W; Roland J; Raulet DH
    Nature; 1995 Jul; 376(6538):355-8. PubMed ID: 7630404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of LY49 NK cell subsets in the regulation of murine cytomegalovirus infections.
    Tay CH; Yu LY; Kumar V; Mason L; Ortaldo JR; Welsh RM
    J Immunol; 1999 Jan; 162(2):718-26. PubMed ID: 9916691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Developmentally regulated extinction of Ly-49 receptor expression permits maturation and selection of NK1.1+ T cells.
    Robson MacDonald H; Lees RK; Held W
    J Exp Med; 1998 Jun; 187(12):2109-14. PubMed ID: 9625772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ligand-dependent inhibition of CD1d-restricted NKT cell development in mice transgenic for the activating receptor Ly49D.
    Voyle RB; Beermann F; Lees RK; Schümann J; Zimmer J; Held W; MacDonald HR
    J Exp Med; 2003 Apr; 197(7):919-25. PubMed ID: 12682111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cutting edge: NKT cell development is selectively impaired in Fyn- deficient mice.
    Eberl G; Lowin-Kropf B; MacDonald HR
    J Immunol; 1999 Oct; 163(8):4091-4. PubMed ID: 10510341
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diversity of NK cell receptor repertoire in adult and neonatal mice.
    Kubota A; Kubota S; Lohwasser S; Mager DL; Takei F
    J Immunol; 1999 Jul; 163(1):212-6. PubMed ID: 10384118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interactions of Ly49 family receptors with MHC class I ligands in trans and cis.
    Scarpellino L; Oeschger F; Guillaume P; Coudert JD; Lévy F; Leclercq G; Held W
    J Immunol; 2007 Feb; 178(3):1277-84. PubMed ID: 17237373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of interaction between Ly49 inhibitory receptors and cognate MHC I molecules in IL2-induced development of NK cells in murine bone marrow cell cultures.
    Das A; Saxena RK
    Immunol Lett; 2004 Jul; 94(3):209-14. PubMed ID: 15275968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acquisition of Ly49 receptor expression by developing natural killer cells.
    Dorfman JR; Raulet DH
    J Exp Med; 1998 Feb; 187(4):609-18. PubMed ID: 9463411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Presence of a novel subset of NKT cells bearing an invariant V(alpha)19.1-J(alpha)26 TCR alpha chain.
    Shimamura M; Huang YY
    FEBS Lett; 2002 Apr; 516(1-3):97-100. PubMed ID: 11959111
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NK cells developing in vitro from fetal mouse progenitors express at least one member of the Ly49 family that is acquired in a time-dependent and stochastic manner independently of CD94 and NKG2.
    Fraser KP; Gays F; Robinson JH; van Beneden K; Leclercq G; Vance RE; Raulet DH; Brooks CG
    Eur J Immunol; 2002 Mar; 32(3):868-78. PubMed ID: 11870631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Class I MHC-binding characteristics of the 129/J Ly49 repertoire.
    Makrigiannis AP; Pau AT; Saleh A; Winkler-Pickett R; Ortaldo JR; Anderson SK
    J Immunol; 2001 Apr; 166(8):5034-43. PubMed ID: 11290784
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immediate antigen-specific effector functions by TCR-transgenic CD8+ NKT cells.
    Wingender G; Berg M; Jüngerkes F; Diehl L; Sullivan BA; Kronenberg M; Limmer A; Knolle PA
    Eur J Immunol; 2006 Mar; 36(3):570-82. PubMed ID: 16506291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influenza Virus Targets Class I MHC-Educated NK Cells for Immunoevasion.
    Mahmoud AB; Tu MM; Wight A; Zein HS; Rahim MM; Lee SH; Sekhon HS; Brown EG; Makrigiannis AP
    PLoS Pathog; 2016 Feb; 12(2):e1005446. PubMed ID: 26928844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acquisition of external major histocompatibility complex class I molecules by natural killer cells expressing inhibitory Ly49 receptors.
    Sjöström A; Eriksson M; Cerboni C; Johansson MH; Sentman CL; Kärre K; Höglund P
    J Exp Med; 2001 Nov; 194(10):1519-30. PubMed ID: 11714758
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Major histocompatibility complex genes determine natural killer cell tolerance.
    Dorfman JR; Raulet DH
    Eur J Immunol; 1996 Jan; 26(1):151-5. PubMed ID: 8566058
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Critical residues at the Ly49 natural killer receptor's homodimer interface determine functional recognition of m157, a mouse cytomegalovirus MHC class I-like protein.
    Kielczewska A; Kim HS; Lanier LL; Dimasi N; Vidal SM
    J Immunol; 2007 Jan; 178(1):369-77. PubMed ID: 17182575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of the Ly49A gene in murine natural killer cell clones is predominantly but not exclusively mono-allelic.
    Held W; Raulet DH
    Eur J Immunol; 1997 Nov; 27(11):2876-84. PubMed ID: 9394813
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differentiation of NK1.1+, Ly49+ NK cells from flt3+ multipotent marrow progenitor cells.
    Williams NS; Klem J; Puzanov IJ; Sivakumar PV; Bennett M; Kumar V
    J Immunol; 1999 Sep; 163(5):2648-56. PubMed ID: 10453005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.